Novartis expects the new capacity will allow it to produce all of its key medicines “end to end” in the U.S., as the Trump administration buffets global trade with tariffs.
Categories:
Related Post
Tutor Perini sub wins $900M USACE job in Israel
The $900 million contract from the Corps’ Middle East District will leverage Perini Management Services…
Lessons from Maine’s data center moratorium debate for construction
Data center partners at K&L Gates, a Pittsburgh-based law firm, discuss statewide limits, the 20-megawatt…
PCL to open Phoenix office
A 20-year company vet will lead the charge in the contractor's push to bolster its…